"a reduction in headcount, ● a reduction in marketing expenditure for FY24, ● a change to its marketing resource providers, ● a reduction in board and management remuneration"
I only ask cause these are pretty much the problems I mentioned recently with the balance sheet. Great to see rather than a CR at 3 cents
Also; "Rhinomed will seek to achieve cash flow breakeven in the second half of FY24"
A little late but very much needed. GLTAH.
RNO Price at posting:
3.5¢ Sentiment: Buy Disclosure: Held